EUVIMEDEUVIMED entdecken
Crossref

Therapeutic Potential of Diosgenin in Amelioration of Carbon Tetrachloride-Induced Murine Liver Injury

Mohamad-Hasan Ghosian-Moghaddam, Parvaneh Mohseni-Moghaddam, Mehrdad Roghani iD

Drug Research · 01.04.2024 · 74 (04) · 156-163

DOI: 10.1055/a-2263-1329 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Research, erschienen am 01.04.2024. Verfasst von Mohamad-Hasan Ghosian-Moghaddam und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Medicine, Shahed University, Tehran, Iran. Hauptthemen laut MEDLINE: Antioxidants, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diosgenin is a sapogenin with antidiabetic, antioxidant, and anti-inflammatory properties. The current study investigated whether diosgenin could ameliorate carbon tetrachloride (CCL4)-induced liver injury. To cause liver injury, CCL4 was injected intraperitoneally twice a week for 8 weeks. Daily oral administration of diosgenin at doses of 20, 40, and 80 mg/kg was started one day before CCL4 injection and continued for 8 weeks. Finally, serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and also albumin were assessed. Catalase and superoxide dismutase (SOD) activities in addition to glutathione (GSH) and malondialdehyde (MDA) levels were also quantified in the liver homogenate and routine histological evaluation was also conducted. Elevated serum levels of liver enzymes and decreased serum level of albumin caused by CCL4 were significantly restored following diosgenin administration at doses of 40 and 80 mg/kg. Long-term administration of CCL4 increased inflammatory and apoptotic factors such as IL-1β, caspase 3, TNF-α, and IL-6 and decreased SOD and catalase activities as well as GSH level in liver homogenates; while MDA level was increased. Treatment with diosgenin increased SOD and catalase activities and GSH levels in the liver of injured animals. In addition, liver MDA, IL-1β, caspase 3, TNF-α, and IL-6 level or activity decreased by diosgenin treatment. Additionally, diosgenin aptly prevented aberrant liver histological changes. According to obtained results, diosgenin can dose-dependently diminish CCl4-induced liver functional deficits and histological changes in a dose-dependent manner, possibly due to its antioxidant and anti-inflammation properties, and its beneficial effect is comparable to known hepatoprotective agent silymarin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntioxidantsChemical and Drug Induced Liver InjuryMiceAnimalsCarbon TetrachlorideCatalaseCaspase 3Tumor Necrosis Factor-alphaInterleukin-6LiverGlutathioneAnti-Inflammatory AgentsSuperoxide DismutaseAlbuminsAlanine Transaminase

Substanzen

AntioxidantsCarbon TetrachlorideCatalaseCaspase 3Tumor Necrosis Factor-alphaInterleukin-6GlutathioneAnti-Inflammatory AgentsSuperoxide DismutaseAlbumins

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Medicine, Shahed University, Tehran, Iran.
  • Department of Physiology, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  • Neurophysiology Research Center, Shahed University, Tehran, Iran.

ORCID-Profile: Mehrdad Roghani

Zitieren

APA

Ghosian-Moghaddam, M. H., Mohseni-Moghaddam, P., & Roghani, M. (2024). Therapeutic Potential of Diosgenin in Amelioration of Carbon Tetrachloride-Induced Murine Liver Injury. Drug Research, 74(04), 156-163. https://doi.org/10.1055/a-2263-1329

Vancouver

Ghosian-Moghaddam MH, Mohseni-Moghaddam P, Roghani M. Therapeutic Potential of Diosgenin in Amelioration of Carbon Tetrachloride-Induced Murine Liver Injury. Drug Research. 2024;74(04):156-163. doi:10.1055/a-2263-1329

BibTeX
@article{GhosianMoghaddam2024,
  author = {Ghosian-Moghaddam, Mohamad-Hasan and Mohseni-Moghaddam, Parvaneh and Roghani, Mehrdad},
  title = {Therapeutic Potential of Diosgenin in Amelioration of Carbon Tetrachloride-Induced Murine Liver Injury},
  journal = {Drug Research},
  year = {2024},
  volume = {74},
  number = {04},
  pages = {156--163},
  doi = {10.1055/a-2263-1329}
}
Kostenlos starten →